MABS-03

N/A

Report date: 2024/08/12 17:58:23

Base Information

Drug NameMABS-03
Drug Alias NameMABS-03
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionRNA inhibitors
TargetsRibonucleic Acid
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesManhattan BioSolutions Inc
China Registration ClassN/A

Develop Information

Active CompaniesManhattan BioSolutions Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A